Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study

Autor:	Hatice Gamze Demirdag, Basak Yalici-Armagan, Burcu Tuğrul Ayanoğlu
Rok vydání:	2019
Předmět:	Adult Male medicine.medical_specialty Epidermal Growth Factor Receptor Inhibitors Cetuximab Antineoplastic Agents Toxicology Acneiform eruption 030207 dermatology & venereal diseases 03 medical and health sciences Erlotinib Hydrochloride 0302 clinical medicine medicine Humans Molecular Targeted Therapy Adverse effect Papulopustular rash Aged Retrospective Studies Aged 80 and over integumentary system business.industry Panitumumab Pruritus Retrospective cohort study Lapatinib General Medicine Exanthema Middle Aged Dermatology ErbB Receptors Tumour therapy 030221 ophthalmology & optometry Female Drug adverse effect medicine.symptom business
Zdroj:	Cutaneous and ocular toxicology. 38(3)
ISSN:	1556-9535
Popis:	Background: Papulopustular rash is the most common cutaneous adverse effect during targeted tumour therapy particularly with epidermal growth factor receptor inhibitors (EGFRIs).Objective: ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7388d8b383abd5d48283033f9445202 https://pubmed.ncbi.nlm.nih.gov/31010330 Zobrazit plný text záznamu